Valuation: Novogenia AG

Market Cap 78M 89.26M 71.98M 66.34M 125M 8.6B 128M 860M 338M 4.21B 335M 328M 14.49B P/E 2025
155x
P/E 2026 * -12.7x
Enterprise Value 21.9M 25.06M 20.21M 18.63M 35.11M 2.41B 35.89M 242M 95.01M 1.18B 94.11M 92.05M 4.07B EV / Sales 2025
0.85x
EV / Sales 2026 * 1.16x
Free-Float
42.5%
Yield 2025 *
6.23%
Yield 2026 * 6.62%
1 day+15.79%
Current month-7.69%
1 month-3.65%
3 months-25.00%
6 months-20.48%
Current year-15.92%
1 week 5.7
Extreme 5.7
6.65
1 month 5.7
Extreme 5.7
7.9
Current year 5.7
Extreme 5.7
12.1
1 year 5.5
Extreme 5.5
12.1
3 years 4.8
Extreme 4.8
12.1
5 years 4.8
Extreme 4.8
12.1
10 years 4.8
Extreme 4.8
12.1
Manager TitleAgeSince
Chief Executive Officer 43 2021-03-14
Director of Finance/CFO - -
Chief Investment Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member - -
Chairman 63 2021-06-22
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+15.79%0.00% - - 89.26M
-0.49%-4.01%+0.61%+2.28% 49.18B
-0.78%+0.42%+380.78%+588.72% 39.58B
-0.15%+2.80%+7.03%+61.99% 34.69B
-1.04%-1.61%+28.46%-9.79% 34.42B
-1.82%-1.48%+0.52%+32.02% 27.11B
-1.30%-2.90% - - 16.21B
-0.46%+0.86%+73.12%+116.58% 15.36B
+1.17%+2.30%+15.46%+18.26% 14.05B
-2.83%-0.28%+18.63%-33.05% 13.02B
Average +0.87%-0.17%+65.58%+97.13% 27.07B
Weighted average by Cap. -0.69%-0.38%+78.80%+121.85%

Financials

2025 2026 *
Net sales 56M 64.09M 51.68M 47.64M 89.78M 6.17B 91.78M 618M 243M 3.02B 241M 235M 10.41B 57.25M 65.51M 52.83M 48.69M 91.78M 6.31B 93.82M 631M 248M 3.09B 246M 241M 10.64B
Net income 3.3M 3.78M 3.05M 2.81M 5.29M 364M 5.41M 36.4M 14.32M 178M 14.18M 13.87M 613M -6.1M -6.98M -5.63M -5.19M -9.78M -672M -10M -67.28M -26.46M -329M -26.21M -25.64M -1.13B
Net Debt -56.1M -64.19M -51.77M -47.72M -89.94M -6.18B -91.93M -619M -243M -3.03B -241M -236M -10.42B -11.6M -13.27M -10.7M -9.87M -18.6M -1.28B -19.01M -128M -50.32M -626M -49.85M -48.76M -2.16B
Logo Novogenia AG
Novogenia AG, formerly Darwin AG, is a Germany-based company, which operates as a biotechnology company. The Company is engaged in production and distribution of personalized dietary supplements and cosmetics. It offers Deoxyribonucleic Acid (DNA), genetic and blood analyses in the lifestyle segment. In addition, test results are primarily used to produce dietary supplements and cosmetics. The Company is active in Pharmaceutical and medical device trading segment as well. It uses artificial intelligence (AI) to create personalized solutions from scientific laboratory analysis data (personalized infusion therapies and In Vitro Fertilization (IVF)/reproductive genetics).
Employees
204
Date Price Change Volume
26-07-20 6.600 +15.79% 100
26-07-17 €5.700 -9.52% 0
26-07-16 €6.300 -3.08% 50
26-07-15 €6.500 -1.52% 0
26-07-14 €6.600 0.00% 0
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.500EUR
Average target price
19.38EUR
Spread / Average Target
+198.08%

Annual profits - Rate of surprise